The adult CNS can adapt to and compensate for deficits in neurologic function after CNS injury or neurodegenerative disease, an effect that contributes to typically less severe clinical symptoms than the magnitude of neuronal damage. Microglia, CNS resident immune cells, play fundamental roles in brain health and disease and are essential neuron partners, but little is understood about how their activities contribute to endogenous mechanisms of CNS repair and adaptation to a chronic neuroinflammatory insult. Here we focus on the mechanisms that control microglial transition from the pro-inflammatory to the anti- inflammatory/neurosupportive phenotype over the course of a chronic disease that affects millions of Americans. We will use exposure to chronic intermittent hypoxia (CIH), a hallmark of sleep apnea that causes significant cognitive and learning impairments in humans and animal models, and that is experienced in more than half of patients with other neurological diseases and injuries. We have identified two primary phases of CIH neuropathology, an acute pro-inflammatory phase that coincides with hippocampal neuron loss and impaired hippocampal plasticity (long-term potentiation; LTP), and a late phase in which microglia produce neurotrophic factors and neurocognitive behaviors partially recover. Our data suggest that the signaling activities of the Toll-like receptor 4 (TLR4), an innate immune receptor that is most often associated with pro- inflammatory microglial responses, may contribute to the beneficial effects of microglia late in CIH pathology. We find TLR4-dependent upregulation of an anti-inflammatory microRNA during CIH that functions to suppress the pro-inflammatory activities of the canonical MyD88-dependent TLR4 signaling pathway. TLR4 signaling also promotes BDNF production which is required for hippocampal LTP and neuron survival, and we find that microglial BDNF expression temporally mirrors early hippocampal LTP loss and later recovery of learning during CIH. Thus, our overarching hypothesis is that early pro-inflammatory TLR4 signaling is later repressed by TLR4-dependent miRNAs that ultimately promote microglial transition to the neurotrophic phenotype, helping to limit neuronal damage and support recovery of hippocampal neuroplasticity during continued CIH pathology.
Four specific aims will be pursued using the shared power of genetic/biochemical studies in transgenic mice, multi-color flow cytometry, and hippocampal slice electrophysiology.
The aims will test the role of TLR4 and its signaling pathways in orchestrating the beneficial effects of microglia, as well as the requirement for microglial BDNF in limiting neuronal loss and recovering hippocampal plasticity in the late phase of CIH. Results from these studies will identify mechanisms by which microglia adapt to enduring neuroinflammatory disease to limit injury and help promote recovery of neuronal function. Mechanisms identified here may be harnessed for therapeutic benefit to enhance ongoing, endogenous neural repair mechanisms for many disorders in which intermittent hypoxia and/or microglia play a role.

Public Health Relevance

Microglia (resident CNS immune cells) play critical roles in virtually all aspects of brain health and disease by performing surveillance, inflammatory, and neuronal support activities, functions between which microglia readily and appropriately shift in the healthy CNS to compensate for and adapt to injury or disease. However, only recently have these neurosupportive/neurotrophic activities that are central to the recovery of neural function come to be appreciated, so little is yet understood about their underlying regulatory mechanisms. The goal of the present study is to begin to identify and understand the cellular and epigenetic mechanisms regulating microglial transition to the beneficial phenotype in chronic neuroinflammatory disease, so that these activities can be manipulated for therapeutic benefit.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS085226-04
Application #
9523216
Study Section
Cellular and Molecular Biology of Glia Study Section (CMBG)
Program Officer
Morris, Jill A
Project Start
2015-07-01
Project End
2020-06-30
Budget Start
2018-07-01
Budget End
2019-06-30
Support Year
4
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Wisconsin Madison
Department
Biology
Type
Schools of Veterinary Medicine
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Johnson, Stephen M; Randhawa, Karanbir S; Epstein, Jenna J et al. (2018) Gestational intermittent hypoxia increases susceptibility to neuroinflammation and alters respiratory motor control in neonatal rats. Respir Physiol Neurobiol 256:128-142
Dougherty, Brendan J; Kopp, Elizabeth S; Watters, Jyoti J (2017) Nongenomic Actions of 17-? Estradiol Restore Respiratory Neuroplasticity in Young Ovariectomized Female Rats. J Neurosci 37:6648-6660
Zhao, Lei; Li, Jun; Fu, Yingmei et al. (2017) Photoreceptor protection via blockade of BET epigenetic readers in a murine model of inherited retinal degeneration. J Neuroinflammation 14:14
Nikodemova, Maria; Small, Alissa L; Kimyon, Rebecca S et al. (2016) Age-dependent differences in microglial responses to systemic inflammation are evident as early as middle age. Physiol Genomics 48:336-44